Tiny particles pack chemo punch for tough bladder cancer

NCT ID NCT05519241

Recruiting now Disease control Sponsor: VA Office of Research and Development Source: ClinicalTrials.gov ↗

First seen Oct 31, 2025 · Last updated May 20, 2026 · Updated 28 times

Summary

This early-stage trial tests a new drug called PPM, which are tiny particles that carry chemotherapy directly to bladder cancer cells. The study is for people with non-muscle-invasive bladder cancer that did not get better with the standard BCG treatment. Up to 29 participants will receive the drug through a catheter into the bladder. The main goals are to find the safest dose and check for side effects, while also seeing if the drug can shrink or eliminate the cancer.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NON-MUSCLE INVASIVE BLADDER CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA
RECRUITING

Boston, Massachusetts, 02130-4817, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact

Conditions

Explore the condition pages connected to this study.

NON-MUSCLE INVASIVE BLADDER CANCER NON-MUSCLE INVASIVE BLADDER CANCER